News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
851,695 Results
Type
Article (86775)
Company Profile (704)
Press Release (764214)
Multimedia
Podcasts (141)
Webinars (18)
Section
Business (232784)
Career Advice (4132)
Deals (39751)
Drug Delivery (129)
Drug Development (91075)
Employer Resources (198)
FDA (18166)
Job Trends (17358)
News (396745)
Policy (39804)
Tag
Academia (3002)
Academic (2)
Accelerated approval (9)
Adcomms (32)
Allergies (104)
Alliances (56961)
ALS (115)
Alzheimer's disease (1546)
Antibody-drug conjugate (ADC) (186)
Approvals (18115)
Artificial intelligence (383)
Autoimmune disease (35)
Automation (18)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (127)
Biotechnology (481)
Bladder cancer (96)
Brain cancer (38)
Breast cancer (381)
Cancer (2977)
Cardiovascular disease (238)
Career advice (3539)
Career pathing (34)
CAR-T (201)
CDC (38)
Cell therapy (555)
Cervical cancer (24)
Clinical research (74124)
Collaboration (1066)
Company closure (3)
Compensation (662)
Complete response letters (30)
COVID-19 (2895)
CRISPR (64)
C-suite (324)
Cystic fibrosis (117)
Data (2930)
Decentralized trials (2)
Denatured (49)
Depression (67)
Diabetes (371)
Diagnostics (6968)
Digital health (26)
Diversity (9)
Diversity, equity & inclusion (49)
Drug discovery (172)
Drug pricing (149)
Drug shortages (35)
Duchenne muscular dystrophy (128)
Earnings (97428)
Editorial (48)
Employer branding (25)
Employer resources (168)
Events (131338)
Executive appointments (899)
FDA (19818)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (983)
Gene editing (142)
Generative AI (37)
Gene therapy (424)
GLP-1 (920)
Government (5241)
Grass and pollen (6)
Guidances (180)
Healthcare (20915)
Huntington's disease (31)
IgA nephropathy (41)
Immunology and inflammation (174)
Immuno-oncology (9)
Indications (39)
Infectious disease (3076)
Inflammatory bowel disease (163)
Inflation Reduction Act (13)
Influenza (66)
Intellectual property (119)
Interviews (813)
IPO (17892)
IRA (55)
Job creations (5192)
Job search strategy (2862)
Kidney cancer (15)
Labor market (54)
Layoffs (584)
Leadership (26)
Legal (10131)
Liver cancer (84)
Lung cancer (422)
Lymphoma (206)
Machine learning (9)
Management (65)
Manufacturing (417)
MASH (92)
Medical device (14703)
Medtech (14708)
Mergers & acquisitions (22544)
Metabolic disorders (937)
Multiple sclerosis (103)
NASH (23)
Neurodegenerative disease (137)
Neuropsychiatric disorders (39)
Neuroscience (2269)
NextGen: Class of 2025 (7687)
Non-profit (5089)
Now hiring (48)
Obesity (483)
Opinion (288)
Ovarian cancer (98)
Pain (115)
Pancreatic cancer (117)
Parkinson's disease (197)
Partnered (25)
Patents (304)
Patient recruitment (151)
Peanut (54)
People (65640)
Pharmaceutical (143)
Pharmacy benefit managers (24)
Phase I (22884)
Phase II (32184)
Phase III (24234)
Pipeline (1620)
Policy (231)
Postmarket research (3552)
Preclinical (10333)
Press Release (72)
Prostate cancer (143)
Psychedelics (41)
Radiopharmaceuticals (277)
Rare diseases (502)
Real estate (7399)
Recruiting (75)
Regulatory (27056)
Reports (61)
Research institute (2663)
Resumes & cover letters (650)
Rett syndrome (9)
RNA editing (9)
RSV (54)
Schizophrenia (92)
Series A (165)
Series B (109)
Service/supplier (30)
Sickle cell disease (64)
Special edition (22)
Spinal muscular atrophy (167)
Sponsored (36)
Startups (4300)
State (2)
Stomach cancer (16)
Supply chain (81)
Tariffs (63)
The Weekly (90)
Vaccines (887)
Venture capital (54)
Weight loss (327)
Women's health (48)
Worklife (20)
Date
Today (107)
Last 7 days (566)
Last 30 days (2716)
Last 365 days (34175)
2025 (17234)
2024 (38139)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1272)
Alabama (70)
Alaska (7)
Arizona (280)
Arkansas (14)
Asia (50461)
Australia (8872)
California (7582)
Canada (2325)
China (698)
Colorado (326)
Connecticut (342)
Delaware (198)
Europe (115774)
Florida (1118)
Georgia (259)
Hawaii (2)
Idaho (65)
Illinois (725)
India (32)
Indiana (382)
Iowa (18)
Japan (224)
Kansas (115)
Kentucky (32)
Louisiana (18)
Maine (73)
Maryland (1083)
Massachusetts (5794)
Michigan (273)
Minnesota (475)
Mississippi (3)
Missouri (97)
Montana (32)
Nebraska (26)
Nevada (80)
New Hampshire (73)
New Jersey (2117)
New Mexico (31)
New York (2134)
North Carolina (1221)
North Dakota (10)
Northern California (3263)
Ohio (245)
Oklahoma (16)
Oregon (48)
Pennsylvania (1623)
Puerto Rico (18)
Rhode Island (39)
South America (1654)
South Carolina (35)
South Dakota (1)
Southern California (2787)
Tennessee (126)
Texas (1149)
United States (28663)
Utah (225)
Virginia (206)
Washington D.C. (80)
Washington State (672)
West Virginia (4)
Wisconsin (83)
There are 851,695 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
OPKO Health and Entera Bio Abstract for First-in-Class Dual GLP-1/Glucagon Tablet Candidate for Patients with Obesity and Metabolic Disorders Selected for Presentation at the ENDO 2025 Annual Meeting
June 25, 2025
·
5 min read
Layoff Tracker
Leap Axes 75% of Staff, Clinical Trial While Considering Strategic Options
Follow along as
BioSpace
tracks job cuts and restructuring initiatives throughout 2025.
June 25, 2025
·
147 min read
·
BioSpace Editorial Staff
Press Releases
Femasys Announces Historic Milestone with European Approval of FemBloc®, the First Non-Surgical Permanent Birth Control
June 25, 2025
·
5 min read
Press Releases
Gilead Sciences and Kymera Therapeutics Enter Into Exclusive Option and License Agreement to Develop Novel Oral Molecular Glue CDK2 Degraders
June 25, 2025
·
10 min read
Press Releases
Petros Pharmaceuticals Announces Deconsolidation of Metuchen Pharmaceuticals Subsidiary, Strengthening its Balance Sheet and Improving the Company’s Equity Position
June 25, 2025
·
6 min read
Press Releases
ONCare Alliance and Exigent Research Launch Groundbreaking Outpatient Bispecifics Program, Redefining Cancer Care Access, Support and Innovation
June 25, 2025
·
3 min read
Press Releases
Jaguar Health to Pursue Approval of Canalevia in European Union for Treatment of General Diarrhea in Dogs
June 25, 2025
·
11 min read
Press Releases
Tobin Scientific Hires Graham Long as Chief Commercial Officer
June 25, 2025
·
3 min read
Press Releases
Alafair Biosciences Announces First Patient Enrolled in Multi-Center Study Evaluating VersaWrap® Tendon Protector for Achilles Repair
June 25, 2025
·
3 min read
Press Releases
Precision BioSciences Receives FDA Rare Pediatric Disease Designation for PBGENE-DMD for the Treatment of Duchenne Muscular Dystrophy
June 25, 2025
·
9 min read
1 of 85,170
Next
